We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$69M
Cap. Flow
+$46.5M
Cap. Flow %
14.94%
Top 10 Hldgs %
34.58%
Holding
105
New
32
Increased
29
Reduced
26
Closed
17

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$11.2M
2
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$7.93M
3
VWR
VWR Corporation
VWR
+$6.84M
4
CTLT
CATALENT, INC.
CTLT
+$6.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$5.82M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$9.69M
2
EHC icon
Encompass Health
EHC
+$5.34M
3
SHPG
Shire pic
SHPG
+$4.9M
4
MCK icon
McKesson
MCK
+$4.57M
5
HOLX
Hologic
HOLX
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 86.32%
2 Financials 3.19%
3 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHC icon
26
Encompass Health
EHC
$11B
$4.71M 1.51%
138,275
-162,656
-54% -$5.34M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$4.63M 1.49%
148,877
-80,900
-35% -$2.19M
CVS icon
28
CVS Health
CVS
$133B
$4.56M 1.47%
58,100
+11,600
+25% +$926K
BCR
29
DELISTED
CR Bard Inc.
BCR
$4.25M 1.37%
17,095
-7,532
-31% -$1.82M
EVHC
30
DELISTED
Envision Healthcare Holdings Inc
EVHC
$4.04M 1.3%
65,900
+10,000
+18% +$670K
ZTS icon
31
Zoetis
ZTS
$32.4B
$4.04M 1.3%
+75,700
New +$4.09M
AKRX
32
DELISTED
Akorn Inc
AKRX
$3.81M 1.22%
158,200
+52,300
+49% +$1.14M
VTRS icon
33
Viatris
VTRS
$20.4B
$3.55M 1.14%
91,100
+24,900
+38% +$1M
MNK
34
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$3.13M 1.01%
70,128
-29,000
-29% -$1.43M
BIIB icon
35
Biogen
BIIB
$30B
$3.07M 0.99%
11,232
+1,700
+18% +$481K
CNC icon
36
Centene
CNC
$30.7B
$3.05M 0.98%
85,552
-41,800
-33% -$1.4M
LH icon
37
Labcorp
LH
$25B
$2.91M 0.94%
23,643
+10,941
+86% +$1.3M
ELGX
38
DELISTED
Endologix Inc
ELGX
$2.42M 0.78%
+33,501
New +$2.22M
KTWO
39
DELISTED
K2M Group Holdings, Inc
KTWO
$2.42M 0.78%
+118,200
New +$2.43M
HALO icon
40
Halozyme
HALO
$9.79B
$2.28M 0.73%
+176,100
New +$2.23M
BBH icon
41
VanEck Biotech ETF
BBH
$400M
$2.2M 0.71%
18,450
-6,200
-25% -$725K
CRL icon
42
Charles River Laboratories
CRL
$11.2B
$2.14M 0.69%
23,788
+5,300
+29% +$450K
CLVS
43
DELISTED
Clovis Oncology, Inc.
CLVS
$2.03M 0.65%
31,850
+13,450
+73% +$818K
MDT icon
44
Medtronic
MDT
$109B
$2.01M 0.65%
+24,900
New +$1.95M
EW icon
45
Edwards Lifesciences
EW
$49.6B
$2M 0.64%
63,948
+32,148
+101% +$1.01M
ILMN icon
46
Illumina
ILMN
$31B
$1.83M 0.59%
+11,000
New +$1.73M
MCK icon
47
McKesson
MCK
$100B
$1.79M 0.57%
12,055
-31,217
-72% -$4.57M
INCY icon
48
Incyte
INCY
$24.2B
$1.76M 0.57%
13,200
-7,000
-35% -$891K
NSTG
49
DELISTED
NanoString Technologies, Inc.
NSTG
$1.75M 0.56%
+88,300
New +$1.68M
TEVA icon
50
Teva Pharmaceuticals
TEVA
$40.8B
$1.69M 0.54%
52,733
+28,800
+120% +$983K
1
2
3 4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Endurant Capital Management held 105 positions worth $311M, up 29% from $242M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management deployed $46.5M of net new capital in Q1 2017, opening 32 new positions and adding to 29 existing holdings. Its largest new stake was Universal Health Services: 95,100 shares worth $11.8M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 88% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Encompass Health, an estimated $5.34M trimmed.

  • Endurant Capital Management's largest Q1 2017 buy was Universal Health Services: 95,100 shares worth $11.8M.
  • Endurant Capital Management added most to Oxford Immunotec Global PLC Ordinary Shares in Q1 2017, an estimated $7.93M increase.
  • Endurant Capital Management's biggest Q1 2017 reduction was Encompass Health, cutting an estimated $5.34M.
  • Endurant Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $9.69M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $311M portfolio in Q1 2017.
  • Endurant Capital Management opened 32 new positions and closed 17 in Q1 2017.
  • Endurant Capital Management's portfolio value rose 29% quarter-over-quarter to $311M.

Based on Endurant Capital Management's 13F filing for Q1 2017, filed 15 May 2017.